Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients
- PMID: 15848328
- DOI: 10.1016/j.ejcts.2005.01.027
Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients
Abstract
Objective: The right internal thoracic artery is being used infrequently despite favorable observational angiographic data. Conversely, the radial artery utilization has increased with only limited data available. The purpose of this paper is to re-evaluate the roles of the right internal thoracic artery and the radial artery grafts.
Methods: We reviewed all ischemia-directed coronary angiographic procedures from January 1996 to December 2003. A total of 219 patients had primary coronary artery bypass grafting with an internal thoracic artery and a radial artery as two of the bypass grafts. Six hundred and seventy-nine (679) graft angiograms (45 saphenous vein, 363 radial artery, 54 right internal thoracic artery and 217 left internal thoracic artery) were studied. The mean period from operation to re-angiogram was 1104+/-761 days. Angiographic outcomes were divided into groups as: (1) patent (<50% stenosis) or (2) failed (>or=50% stenosis, string sign or occluded). A generalized linear mixed model was used to analyze predictors of graft patency. Turnbull's estimates of cumulative patency were used to compare graft failure rates over time.
Results: A total of 632/679 (93%) grafts were patent and 47/679 (7%) grafts had failed. Empirical saphenous vein graft patency was 40/45 (89%), radial artery patency 329/363 (91%), right internal thoracic artery patency 51/54 (94%) and left internal thoracic artery patency 212/217 (98%). Pairwise comparisons of patency from the generalized linear mixed model were: LITA>RITA, OR=1.5 (P=0.5); LITA>RA, OR=5.7 (P<0.001); LITA>SV, OR=6.5 (P<0.001); RITA>RA, OR=3.9 (P=0.01); RITA>SV, OR=4.4 (P=0.01); RA>SV, OR=1.1 (P=0.7). Five-year patency estimates from the Turnbull's model were the left internal thoracic artery (95.9%), right internal thoracic artery (91.2%), the radial artery (90.6%) and the saphenous vein (81.8%).
Conclusions: Consideration should be given to the routine use of both internal thoracic arteries for coronary artery bypass grafting. When additional grafts are required, there is no evidence to suggest that either the radial artery or saphenous vein is superior.
Comment in
-
Arterial versus vein graft patency in coronary artery bypass grafting patients with ischemia-directed repeat angiography.Eur J Cardiothorac Surg. 2005 Sep;28(3):510-1; author reply 511-2. doi: 10.1016/j.ejcts.2005.06.013. Eur J Cardiothorac Surg. 2005. PMID: 16111615 No abstract available.
Similar articles
-
The right internal thoracic artery: the forgotten conduit--5,766 patients and 991 angiograms.Ann Thorac Surg. 2011 Jul;92(1):9-15; discussion 15-7. doi: 10.1016/j.athoracsur.2011.03.099. Ann Thorac Surg. 2011. PMID: 21718825
-
Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.Circulation. 2004 May 4;109(17):2086-91. doi: 10.1161/01.CIR.0000127570.20508.5C. Circulation. 2004. PMID: 15123539 Review.
-
The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.Ann Thorac Surg. 2013 Jul;96(1):105-11. doi: 10.1016/j.athoracsur.2013.01.102. Epub 2013 May 16. Ann Thorac Surg. 2013. PMID: 23684156 Clinical Trial.
-
Comparison of patency between radial artery and saphenous vein in a coronary artery bypass grafting post operative with return of the symptoms.Rev Bras Cir Cardiovasc. 2010 Apr-Jun;25(2):218-23. doi: 10.1590/s0102-76382010000200014. Rev Bras Cir Cardiovasc. 2010. PMID: 20802914 English, Portuguese.
-
Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials.J Thorac Cardiovasc Surg. 2013 Aug;146(2):255-61. doi: 10.1016/j.jtcvs.2012.07.014. Epub 2012 Aug 4. J Thorac Cardiovasc Surg. 2013. PMID: 22871565 Review.
Cited by
-
Smooth muscle cell fate and plasticity in atherosclerosis.Cardiovasc Res. 2018 Mar 15;114(4):540-550. doi: 10.1093/cvr/cvy022. Cardiovasc Res. 2018. PMID: 29385543 Free PMC article. Review.
-
Current status of coronary artery bypass grafting.Gen Thorac Cardiovasc Surg. 2008 Jun;56(6):260-7. doi: 10.1007/s11748-008-0251-x. Epub 2008 Jun 18. Gen Thorac Cardiovasc Surg. 2008. PMID: 18563520 Review.
-
The Tissue-Engineered Vascular Graft-Past, Present, and Future.Tissue Eng Part B Rev. 2016 Feb;22(1):68-100. doi: 10.1089/ten.teb.2015.0100. Epub 2015 Oct 8. Tissue Eng Part B Rev. 2016. PMID: 26447530 Free PMC article.
-
Comparative genome-wide transcriptional analysis of human left and right internal mammary arteries.Genomics. 2014 Jul;104(1):36-44. doi: 10.1016/j.ygeno.2014.04.005. Epub 2014 May 20. Genomics. 2014. PMID: 24858532 Free PMC article.
-
No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.BMJ. 2025 Apr 30;389:e082883. doi: 10.1136/bmj-2024-082883. BMJ. 2025. PMID: 40306935 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical